Cargando…

Outcomes in Patients with Liver Dysfunction Post SARS-CoV-2 Infection: What Should We Measure?

AIM: Since 2019, the COVID-19 pandemic wreaked havoc all over the world. Early in the course of the pandemic, multiple hepatic manifestations of COVID-19 were noted. We aim to categorize hepatic dysfunction and its outcome in COVID-19 infection. METHODS: This is a review article based on a literatur...

Descripción completa

Detalles Bibliográficos
Autores principales:	John, Nimy, Ibrahim, Brittney, Ebaid, Mark, Saab, Sammy
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10578169/ https://www.ncbi.nlm.nih.gov/pubmed/37850074 http://dx.doi.org/10.2147/HMER.S371507

Ejemplares similares

Immunity to SARS-CoV-2: What Do We Know and Should We Be Testing for It?
por: Misra, Anisha, et al.
Publicado: (2022)

Supporting hemodynamics: what should we target? What treatments should we use?
por: Gattinoni, Luciano, et al.
Publicado: (2013)

Should we unstress SARS-CoV-2 infected cells?
por: Csukasi, Fabiana, et al.
Publicado: (2020)

Should we vaccinate children against SARS-CoV-2?
por: The Lancet Infectious Diseases
Publicado: (2021)

Should we test asymptomatic children for SARS-CoV-2?
por: Cowan, Kirsty, et al.
Publicado: (2021)

What Should We Eat?
Publicado: (1909)

SARS-CoV-2 vs. Hepatitis Virus Infection Risk in the Hemodialysis Population: What Should We Expect?
por: D’Marco, Luis, et al.
Publicado: (2021)

AB089. What should we know role of finasteride in erectile dysfunction?
por: Shin, Yu Seob, et al.
Publicado: (2018)

The impact of public involvement in health research: what are we measuring? Why are we measuring it? Should we stop measuring it?
por: Russell, Jill, et al.
Publicado: (2020)

Liver Transplantation for Intrahepatic Cholangiocarcinoma: What Are New Insights and What Should We Follow?
por: Sun, Dawei, et al.
Publicado: (2022)

Omicron SARS-CoV-2 variant: What we know and what we don’t
por: Ferré, Valentine Marie, et al.
Publicado: (2022)

SARS-CoV-2 and neurodegenerative diseases: what we know and what we don’t
por: Lingor, Paul, et al.
Publicado: (2022)

Should we expect neurological symptoms in the SARS-CoV-2 epidemic?()
por: Matías-Guiu, J., et al.
Publicado: (2020)

SARS-CoV-2: Should We Be Concerned about the Nervous System?
por: Silva, Marcus Tulius T., et al.
Publicado: (2020)

Multimorbidity: What do we know? What should we do?
por: Navickas, Rokas, et al.
Publicado: (2016)

Glucose-6-phosphate dehydrogenase deficiency and SARS-CoV-2 mortality: Is there a link and what should we do?
por: Nabavi, Seyed Fazel, et al.
Publicado: (2020)

SARS-CoV-2 vaccination in liver transplant recipients: We still haven't found what we are looking for
por: Thompson, Marcos A., et al.
Publicado: (2023)

What Fillings Should We Use
por: Bonwill, W. G. A.
Publicado: (1885)

Cardiovascular assessment in liver transplant for non-alcoholic steatohepatitis patients: What we do, what we should do
por: Sanchez-Torrijos, Yolanda, et al.
Publicado: (2017)

Bronchoalveolar lavage fluid dilution in ICU patients: what we should know and what we should do
por: Yu, Yuetian, et al.
Publicado: (2019)

Neurologic Complications With Vaccines: What We Know, What We Don't, and What We Should Do
por: Nath, Avindra
Publicado: (2023)

Should we modulate the neonatal microbiome and what should be the goal?
por: van Best, Niels, et al.
Publicado: (2022)

What we know and what we need to know about the origin of SARS-CoV-2
por: Domingo, Jose L.
Publicado: (2021)

Post-hepatectomy liver failure: Should we consider venous outflow?
por: Lhuaire, Martin, et al.
Publicado: (2015)

The SARS-CoV-2 outbreak: What we know
por: Wu, Di, et al.
Publicado: (2020)

Post-Viral Olfactory Loss: What We Learned from the SARS-CoV-2 Pandemic
por: Vaira, Luigi Angelo, et al.
Publicado: (2022)

What the neuroradiologist should additionally consider in SARS-CoV-2 infection
por: Finsterer, J., et al.
Publicado: (2020)

COVID-19 vaccine: what are we doing and what should we do?
por: Candelli, Marcello
Publicado: (2022)

Neuropathic pain; what we know and what we should do about it
por: Smith, Peter A.
Publicado: (2023)

Liver injury, SARS‐COV‐2 infection and COVID‐19: What physicians should really know?
por: Licata, Anna, et al.
Publicado: (2021)

Safer Singing During the SARS-CoV-2 Pandemic: What We Know and What We Don't
por: Naunheim, Matthew R., et al.
Publicado: (2021)

Biomarkers to Measure Treatment Effects in Alzheimer's Disease: What Should We Look for?
por: Rockwood, Kenneth
Publicado: (2011)

Men's Health: What Should We Know?
por: Kim, Sae Woong
Publicado: (2015)

By What Standard Should We Manage Diabetes?
por: Brunton, Stephen
Publicado: (2018)

What Kind of Shoes We Should Wear
por: Robinson, G. P.
Publicado: (1899)

What should we do about monkeypox?
por: Chen, Si, et al.
Publicado: (2022)

What we should focus on and reach out to
por: Nishimura, T.
Publicado: (2023)

Immunopathology and Immunopathogenesis of COVID-19, what we know and what we should learn
por: Shahgolzari, Mehdi, et al.
Publicado: (2021)

Multinational monkeypox outbreak: what do we know and what should we do?
por: Memariani, Mojtaba, et al.
Publicado: (2022)

Quality Indicators for Human Milk Use in Very Low Birthweight Infants: Are We Measuring What We Should be Measuring?
por: Bigger, Harold R., et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_qj3c1l8hfm150c9ieptailfr89